Bacille Calmette-Guérin revaccination is not efficacious for preventing sustained Mycobacterium tuberculosis infection.

The Food and Drug Monitoring Agency (BPOM) has authorized phase 3 clinical trials of the M72 tuberculosis (TB) vaccine in ...

The WHO recommends vaccination against 12 deadly diseases in childhood, but how long does protection last, and how do they ...

A prior phase II trial had shown that BCG revaccination in teens led to 45.4% efficacy in reversion from positive to negative ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

Treatment with a custom-made vaccine combination was found to be safe and feasible for patients with bladder cancer, ...

The immune system can work in two ways: the innate immune system reacts to any foreign invaders that are identified by immune cells that look... | Cell And Molecular Biology ...

The head of Pasteur Institute of Iran (PII) announced the export of more than 700,000 doses of the BCG vaccine to the ...

Lactate, a product of scaled-up energy production, appears to play a key role in inducing trained immunity after vaccines.

BCG (Bacillus Calmette - Guerin) vaccine is made from a treated (attenuated) live strain of bacterium derived from Mycobacterium bovis, a bacterium which typically causes tuberculosis (TB ...

China: A recent systematic review and meta-analysis has reaffirmed the protective effect of the Bacillus Calmette-Guérin (BCG ...

The trial included 1,836 participants: 918 were randomly allocated to receive the BCG vaccine and 917 to receive placebo. The researchers observed a sustained QFT conversion in 62 of 871 and 59 of ...